Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
3 S&P 500 Stocks For Your December 2022 Watchlist
02:00pm, Tuesday, 29'th Nov 2022
Check out these three S&P 500 stocks ahead of December 2022.
Lilly Confirms Date and Conference Call for 2023 Financial Guidance Announcement
10:00am, Tuesday, 29'th Nov 2022
INDIANAPOLIS , Nov. 29, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial guidance for 2023 on Tuesday, Dec. 13, 2022. Lilly will also conduct a conference call on tha
4 Pharmaceutical Companies Among 19 To Announce Annual Dividend Increases In December
05:00am, Monday, 28'th Nov 2022
Among the 19 companies that are expected to announce annual dividend increases in December are drugmakers Eli Lilly, Pfizer, Bristol Myers Squibb, and Amgen. Investors are also waiting for Merck's inc
Up 32% in 2022, Is Eli Lilly Stock Still a Buy?
07:30am, Sunday, 27'th Nov 2022
In the market meltdown of 2022, this pharmaceutical stock bucked the trend and rose significantly.
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
10:32am, Wednesday, 23'rd Nov 2022
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Eli Lilly: Don't Take This Medicine
11:07am, Monday, 21'st Nov 2022
Eli Lilly and Company is fairly new to the dividend growth club. The company is finally growing robustly again.
‘More work to do': Eli Lilly admits insulin pricing could be lower amid Twitter chaos
01:18pm, Saturday, 19'th Nov 2022
Furor over platform's verified profiles may have done some good, but challenges still plague the site after a mass worker exodus
Final Trades: Nvidia, Uber, Eli Lilly & more
09:05am, Saturday, 19'th Nov 2022
The "Halftime Report" traders give their top picks to watch for the second half.
Eli Lilly CEO David Ricks on positive Alzheimer's drug trial data
07:10am, Saturday, 19'th Nov 2022
Eli Lilly said on Monday a trial of its experimental Alzheimer's drug donanemab showed it slowed by about a third the rate of decline in a combined measure of cognition and function in early-stage vic
Eli Lilly's Alzheimer's drug gets FDA breakthrough designation
02:34am, Saturday, 19'th Nov 2022
CNBC's Meg Tirrell reports on how Eli Lilly's will seek FDA approval this year for its Alzheimer's drug.
How Markets Have Fared Under a Divided Congress
01:32pm, Thursday, 17'th Nov 2022
Markets typically applaud the 'certainty' that comes with a split Congress.
American Resources appoints former Eli Lilly executive and Indiana politician Daniel Hasler to board of ReElement Technologies
09:59am, Thursday, 17'th Nov 2022
American Resources Corporation (NASDAQ:AREC) has added former Eli Lilly executive Daniel Hasler to the board of directors at its wholly- owned subsidiary, ReElement Technologies. The appointment come
Eli Lilly (LLY) Stock Up 26.7% YTD: What's in Store for 2023?
09:47am, Wednesday, 16'th Nov 2022
Lilly (LLY) expects to launch five new medicines by 2023-end, including Mounjaro for type II diabetes (already launched) and donanemab for early Alzheimer's disease.
Four Healthcare Stocks To Watch This Week
08:18am, Wednesday, 16'th Nov 2022
Healthcare has long been a wise investment, as the industry consistently grows yearly. Some analysts believe that trend will continue.
Is Eli Lilly Stock a Buy After Last Week's Twitter Prank?
05:52am, Tuesday, 15'th Nov 2022
Forget the Twitter tumult. Lilly is a verified winner.
